Citation profile for Laura Lasio

Laura Lasio : Citation Profile

McGill University (47% share)
Centre Interuniversitaire de Recherche en Économie Quantitative (CIREQ) (47% share)
Centre Interuniversitaire de Recherche en Analyse des Organisations (CIRANO) (6% share)

H index

i10 index

Citations

RESEARCH PRODUCTION:

Articles

Papers

RESEARCH ACTIVITY:

   11 years (2012 - 2023). See details.
   Cites by year: 5
   Journals where Laura Lasio has often published
   Relations with other researchers
   Recent citing documents: 6.    Total self citations: 2 (3.13 %)

MORE DETAILS IN:

EconPapers Author's homepage

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pla850
   Updated: 2025-12-20    RAS profile: 2025-05-16
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Clark, Robert (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Laura Lasio.

Is cited by:

Dubois, Pierre (8)

Sæthre, Morten (6)

Wilner, Lionel (6)

Choné, Philippe (6)

Suppliet, Moritz (6)

D'Haultfoeuille, Xavier (3)

Mendez, Susan (3)

Siotis, Georges (2)

Szücs, Florian (2)

Castanheira, Micael (2)

Ornaghi, Carmine (2)

Cites to:

Brekke, Kurt (5)

Clark, Robert (4)

Nielsen, Morten (3)

Genesove, David (3)

Straume, Odd Rune (3)

MacKinnon, James (3)

Teece, David (3)

Gallouj, Faïz (2)

Webb, Matthew (2)

Dubois, Pierre (2)

Grasdal, Astrid (2)

Main data

Where Laura Lasio has published?

Working Papers Series with more than one paper published	# docs
CRC TR 224 Discussion Paper Series / University of Bonn and University of Mannheim, Germany	2

Recent works citing Laura Lasio (2025 and 2024)

Year	Title of citing document
2025	Does Entry Remedy Collusion? Evidence from the Generic Prescription Drug Cartel. (2025). Starc, Amanda ; Wollmann, Thomas G. In: American Economic Review. RePEc:aea:aecrev:v:115:y:2025:i:5:p:1400-1438. Full description at Econpapers \|\| Download paper
2025	Demand Analysis under Price Rigidity and Endogenous Assortment: An Application to Chinas Tobacco Industry. (2025). Luo, Yao ; Liu, Hui. In: Papers. RePEc:arx:papers:2501.17251. Full description at Econpapers \|\| Download paper
2025	Impact of the COVID-19 pandemic on mental health management: Evidence from individual-level universal insurance claims data. (2025). Kim, Pyoungsik. In: Labour Economics. RePEc:eee:labeco:v:92:y:2025:i:c:s0927537124001696. Full description at Econpapers \|\| Download paper
2024	Passthrough of Retail Price Regulation in the Market for Pharmaceuticals. (2024). Markkanen, Jaakko. In: ETLA Working Papers. RePEc:rif:wpaper:123. Full description at Econpapers \|\| Download paper
2025	Mergers and Advertising in the Pharmaceutical Industry. (2025). Dubois, Pierre ; Majewska, Gosia. In: TSE Working Papers. RePEc:tse:wpaper:127469. Full description at Econpapers \|\| Download paper
2025	Pharmaceutical Regulation and Incentives for Innovation in an International Perspective. (2025). Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:131002. Full description at Econpapers \|\| Download paper

Works by Laura Lasio:

Year	Title	Type	Cited
2018	Identifying Industry Margins with Price Constraints: Structural Estimation on Pharmaceuticals In: American Economic Review. [Full Text][Citation analysis]	article	22
2021	Stigma as a Barrier to Treatment and Adoption of Innovation In: CRC TR 224 Discussion Paper Series. [Full Text][Citation analysis]	paper	1
2023	Biased Beliefs and Stigma as Barriers to Treatment and Innovation Adoption In: CRC TR 224 Discussion Paper Series. [Full Text][Citation analysis]	paper	1
2020	Réduction des délais de négociation des nouveaux médicaments dans les provinces canadiennes : effets sur la santé et sur les dépenses publiques In: CIRANO Project Reports. [Full Text][Citation analysis]	paper	0
2014	Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals In: CEPR Discussion Papers. [Full Text][Citation analysis]	paper	34
2014	Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals.(2014) In: IDEI Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 34	paper
2018	Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals.(2018) In: TSE Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 34	paper
2022	Collusion in the US generic drug industry In: International Journal of Industrial Organization. [Full Text][Citation analysis]	article	3
2021	Collusion in the US Generic Drug Industry.(2021) In: Working Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 3	paper
2013	Diversification strategies in network-based services: The case of mobile virtual network operators In: Telecommunications Policy. [Full Text][Citation analysis]	article	1
2012	The effects of price regulation of pharmaceutical industry margins: A structural estimation for anti-ulcer drugs in France. In: Health, Econometrics and Data Group (HEDG) Working Papers. [Full Text][Citation analysis]	paper	0